Greater Philadelphia sits at the forefront of a dynamic life sciences evolution, where strategic decision-making today will shape the trajectory of the region’s biotech and innovation economy for years to come. As funding landscapes shift, groundbreaking research emerges, and tenant demands evolve, stakeholders across commercial real estate, including developers, investors, and brokers, need critical insights...
Optimize Your Gross-To-Net Strategies to Drive Financial Excellence Save 10% today with VIP code: 25B4B10* The Pharma/Biotech GTN Summit, taking place November 18-20, 2025 in Philadelphia, PA, is a CPE accredited conference designed to equip pharmaceutical and biotech finance professionals with proven methodologies, forecasting models, and automation insights to enhance visibility, profitability, and control in gross-to-net management. Whether your organization is...
The 4th annual Chief Commercial Officer Summit highlights the vision and direction you need for driving commercial growth and excellence. Our all-new agenda helps you build the skills and business acumen to implement strategic, tactical and operational plans for advancing access and propelling commercial growth. This is a tremendous opportunity to join leading commercial executives...
The Most Advanced Conference to Modernize Clinical Research, For Everyone in Clinical Operations The 15th Annual DPHARM® offers an unparalleled opportunity to hear senior clinical operations executives and innovative thought leaders unveil the latest innovations on modernizing clinical trials. DPHARM faculty challenge the clinical operations community to rethink how clinical research gets done to drive...
Become part of a vibrant community committed to breaking barriers and driving meaningful change as we celebrate the 15th Advancing Women’s Leadership in Pharma and Healthcare. By participating, you’ll build confidence in your ability to lead and drive change enterprise-wide as well as across the industry. This popular and highly regarded event provides a powerful...
How to Build an Infrastructure with Sites that Drives more Effective Patient Enrollment and Retention How can pharma/biotech and CROs be better partners to Sites? The Partnerships with Sites Summit challenges the site ecosystem on how to build an infrastructure to drive more effective patient enrollment and retention. This summit provides a timely and focused...
The Conference that Helps You Plan the Convergence Journey of Research and Care Embedding clinical research in the care setting can lead to higher rates of clinical trial participation inside of a health system, better health outcomes, lower cost of care and more satisfied patients. The CRAACO® conference is a unique opportunity for pharma, healthcare...
Biotech Networks is very excited to be hosting an event in our NINTH US city, Philadelphia! We built the PA/NY/NJ hub online and understand the broad geography that it encompasses. Philadelphia is a natural first step for us to visit, as NY and NJ offer some challenges as to where to host an event. Eventually...
The ever-evolving complexities accompanying innovative clinical trial design and implementation require a more strategic and exacting relationship for sites and sponsors. In addition to needing a deep understanding of unique study design to execute it accurately, sites are also facing technology challenges, more diverse patient populations and regulatory scrutiny on data collection and quality. Empowering...
Clinical trial agreements are the backbone of every relationship between sponsors, CROs, and the research institution. Some of the biggest challenges when handlings these agreements are budget negotiation, communication transparency, language determination, and technological advancements. Are you prepared to learn the best strategies on how to accelerate your CTA negotiations? Save the date for August...
Commercializing breakthrough immune-oncology therapeutics is becoming increasingly challenging due to funding limitations, high cost and attrition rates in the clinic, regulatory uncertainties, persistent therapeutic safety and efficacy concerns, and a general lack of understanding of basic biology guiding research in this space. As we develop the 2025 conference program, we are struck by the fact that, despite these challenges, there remains a strong desire to...
